Additionally, BCL2L12 exerts pro-apoptotic effects implicated in various malignancies, including laryngeal squamous cell carcinoma [36], breast cancer [37], and acute myeloid leukemia [38]. This evidence concerns the gene BCL2L12 and laryngeal squamous cell carcinoma.